NCT07520214 2026-04-09
Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
Beijing Neurosurgical Institute
Phase EARLY_PHASE1 Enrolling by invitation
Clinical Trials
5 trialsNCT07503613 2026-04-06
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Akouos, Inc.
Enrolling by invitation
NCT03610906 2026-03-23
Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
University of Colorado, Denver
Enrolling by invitation
NCT06763965 2026-03-23
Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT07126990 2026-03-23
Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation